Delivery Order SPE2DR25D1106-SPE2DR26FJH2C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,195.56 to AmerisourceBergen Drug Corp for the supply of Lyrica 150 mg capsules (90-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Lyrica 150 mg capsules (90-count units) valued at $1,723.91. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by December 31, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,773.39 to AmerisourceBergen Drug Corp for the supply of Lyrica 150 mg capsules (90-count units). This firm fixed price contract, awarded on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Performance will be executed...
- The Defense Logistics Agency awarded a delivery order valued at $1,866.31 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules in unit dose packaging (100 count). The contract, awarded on January 12, 2026, with an ultimate completion date of January 13, 2026, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $3,119.78 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on December 16, 2025, with completion expected by December 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds...
- The Defense Logistics Agency awarded a $1,196.02 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 7, 2026, for the supply of Lyrica 75 mg capsules (90 count). This non-set-aside contract represents a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $2,467.37 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Lyrica 75 mg capsules (quantity of 90 units). This is a firm fixed-price contract with no set-aside designation, competitively awarded through an open process. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company...
- The Defense Logistics Agency awarded a delivery order valued at $1,183.60 to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (90-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lyrica 100 mg capsules (90-count) with a ceiling value of $1,213.60. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded, non-set-aside contract. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $2,336.03 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJH2CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,164.40 to AmerisourceBergen Drug Corp for the supply of Lyrica 150 mg capsules (90-count unit) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. Lyrica, a neurological medication, exemplifies the diverse therapeutic classes of products delivered through this strategic contract vehicle to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/11/26 |